October 2, 2024|Access to MedicinesGilead’s Access Strategy for Lenacapavir Will Unnecessarily Prolong the HIV Pandemic Activists Call for Affordable Access for all Low- and Middle-Income CountriesActivists reacted to Gilead’s announcement of plans to license lenacapavir, a long acting injectable for HIV prevention and treatment, to 6 generic companies that would supply 120 low-  and middle-income countries. Lenacapavir has been shown to be highly effective in…

September 24, 2024|Funding the Fight, Health JusticeActivists: World Bank President Ajay Banga Must Stand Up to Discrimination in Uganda Protest at Uganda’s U.N. Permanent Mission, 336 East 45th St, NY, Thurs Sept. 26 9am(Kampala and New York) One year after the World Bank announced there would be no new financing to Uganda after President Museveni signed a draconian new anti-LGBTQ law, called “among the worst in the world,” Bank President Ajay Banga is…

July 23, 2024|Access to MedicinesActivists at AIDS2024 Demand: Break Gilead’s Lenacapavir Monopoly Gilead’s Price 100,000% Higher than Target Generic Price for 100% Effective Prevention Shot(Munich) Today at AIDS 2024, a coalition of activists called for immediate global action to break Gilead’s monopoly on lenacapavir, in response to new data showing that generic lenacapavir can be produced at a price one thousand times less than…

May 20, 2024|Health JusticeLGBTQ+, HIV Activists Demand U.S. Accountability on Human Rights in Kenya Ahead of President Ruto’s State VisitWhile LGBTQ+ Persecution Increases in Kenya, Ruto Seeks Major Deals with Coca-Cola and other U.S. Companies Lauded for Pro-LGBTQ+ Workplace Policies    (Washington, D.C.) Human rights organizations called on the Biden administration to honor his promise to advance the rights…